糖皮质激素联合特布他林治疗慢阻肺急性加重期的疗效观察
|
摘要
目的分析糖皮质激素联合特布他林在慢阻肺急性加重期治疗中所发挥的效果。方法选择我院在2017年3月至2018年3月诊治的慢阻肺急性加重期患者76例进行研究分析,分为联合组和对照组各38例,联合组采用糖皮质激素联合特布他林治疗,对照组仅给予特布他林治疗,对比两组患者治疗效果和治疗后肺通气功能。结果联合组治疗总有效率为94.74%,显著高于对照组71.05%,联合组治疗后肺通气指标优于对照组,各项数据对比有P<0.05。结论在慢阻肺急性加重期疾病的治疗中采用糖皮质激素联合特布他林能够显著改善患者肺通气功能,促进临床症状缓解,综合疗效好,值得应用。
Objective To analyze effect of glucocorticoid combined with terbutaline in treatment of acute exacerbation of chronic obstructive pulmonary disease. Methods Choose and analyze 76 cases acute exacerbation of chronic obstructive pulmonary disease patients in our hospital from March 2017 to March 2018. Divide them into combination group and control group, 38 cases in each group. Combination group was treated with glucocorticoid combined with terbutaline, while control group with terbutaline only. Compare curative effect and pulmonary ventilation function after treatment between two groups. Results Total effective rate of combination group was 94.74%, significantly higher than 71.05% of control group, pulmonary ventilation index of combination group was better than control group, data comparison showed P<0.05. Conclusion Glucocorticoid combined with terbutaline can improve pulmonary ventilation function and relieve clinical symptoms significantly in treatment of acute exacerbation of chronic obstructive pulmonary disease, which is worthy of application with good comprehensive curative effect.
Objective To analyze effect of glucocorticoid combined with terbutaline in treatment of acute exacerbation of chronic obstructive pulmonary disease. Methods Choose and analyze 76 cases acute exacerbation of chronic obstructive pulmonary disease patients in our hospital from March 2017 to March 2018. Divide them into combination group and control group, 38 cases in each group. Combination group was treated with glucocorticoid combined with terbutaline, while control group with terbutaline only. Compare curative effect and pulmonary ventilation function after treatment between two groups. Results Total effective rate of combination group was 94.74%, significantly higher than 71.05% of control group, pulmonary ventilation index of combination group was better than control group, data comparison showed P<0.05. Conclusion Glucocorticoid combined with terbutaline can improve pulmonary ventilation function and relieve clinical symptoms significantly in treatment of acute exacerbation of chronic obstructive pulmonary disease, which is worthy of application with good comprehensive curative effect.
引文
[1]毛金山,王明朋.糖皮质激素联合特布他林对慢阻肺急性加重期的临床疗效[J].中外医学研究,2018,16(23):30-31.
[2]梁巧明.糖皮质激素联合特布他林治疗慢阻肺急性加重期的疗效观察[J].现代医学与健康研究电子杂志,2018,2(12):55-56.
[3]陈西容.糖皮质激素联合特布他林治疗慢阻肺急性加重期的疗效观察[J].中国社区医师,2018,34(16):19-20.
[4]叶权生.糖皮质激素联合特布他林治疗慢阻肺急性加重期的疗效观察[J].北方药学,2018,15(06):89.
[5]何高云.糖皮质激素联合特布他林对慢阻肺急性加重期的临床疗效观察[J].临床医药文献电子杂志,2018,5(35):18-19.
[6]江焰平.糖皮质激素联合特布他林治疗慢阻肺急性加重期的价值[J].当代医学,2017,23(24):161-162.
[7]刘萍.糖皮质激素联合特布他林治疗慢阻肺急性加重期的疗效观察[J].世界最新医学信息文摘,2018,07:94-96.
[2]梁巧明.糖皮质激素联合特布他林治疗慢阻肺急性加重期的疗效观察[J].现代医学与健康研究电子杂志,2018,2(12):55-56.
[3]陈西容.糖皮质激素联合特布他林治疗慢阻肺急性加重期的疗效观察[J].中国社区医师,2018,34(16):19-20.
[4]叶权生.糖皮质激素联合特布他林治疗慢阻肺急性加重期的疗效观察[J].北方药学,2018,15(06):89.
[5]何高云.糖皮质激素联合特布他林对慢阻肺急性加重期的临床疗效观察[J].临床医药文献电子杂志,2018,5(35):18-19.
[6]江焰平.糖皮质激素联合特布他林治疗慢阻肺急性加重期的价值[J].当代医学,2017,23(24):161-162.
[7]刘萍.糖皮质激素联合特布他林治疗慢阻肺急性加重期的疗效观察[J].世界最新医学信息文摘,2018,07:94-96.